Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide.
-
Wondering whether Lonza Group at about CHF 508 per share still makes sense for your portfolio, or if better value is available elsewhere?
-
The stock has been fairly volatile recently, with a 4.8% decline over the last week, an 8.7% gain over the last month, and returns of 5.1% lower year to date and 8.9% lower over the last year.
-
Recent coverage has focused on how Lonza Group fits into the wider life sciences sector and what that might mean for investor sentiment. This news context helps explain why the share price has moved in both directions over different time frames, as investors reassess expectations and risk.
-
On Simply Wall St's 6 point valuation framework, Lonza Group scores a 2 out of 6. The next sections will walk through what that means across different valuation methods, before closing with a more holistic way to think about value.
Lonza Group scores just 2/6 on our valuation checks. See what other red flags we found in the full valuation breakdown .
Approach 1: Lonza Group Discounted Cash Flow (DCF) Analysis
A Discounted Cash Flow model projects a company's future cash flows and then discounts them back to today's value, aiming to estimate what the business might be worth right now based on those cash flows.
For Lonza Group, the model used is a 2 Stage Free Cash Flow to Equity approach. The latest twelve month free cash flow is a loss of CHF 390.96 million. Analysts and extrapolations then project positive free cash flow, for example CHF 412.61 million in 2026 and CHF 905 million in 2030, with the intermediate and later years based partly on analyst inputs and partly on Simply Wall St extrapolations.
Discounting this series of projected cash flows back to today in CHF results in an estimated intrinsic value of CHF 232.84 per share. Compared with the recent share price around CHF 508, the model implies Lonza Group is about 118.3% above this DCF estimate. This suggests that the shares are trading well above this particular assessment of underlying cash flow value.
Result: OVERVALUED
Our Discounted Cash Flow (DCF) analysis suggests Lonza Group may be overvalued by 118.3%. Discover 237 high quality undervalued stocks or create your own screener to find better value opportunities.
Approach 2: Lonza Group Price vs Earnings
For profitable companies, the P/E ratio is a useful shorthand because it links what you pay per share directly to the earnings that each share generates. It helps you see how many years of current earnings the market is effectively pricing in.
What counts as a "normal" or "fair" P/E depends on how quickly earnings are expected to grow and how risky those earnings appear. Higher expected growth or lower perceived risk can justify a higher P/E, while lower growth expectations or higher risk usually point to a lower one.
Lonza Group currently trades on a P/E of 39.05x. That is above the Life Sciences industry average P/E of 35.34x, but below the peer group average of 48.77x. Simply Wall St also calculates a proprietary "Fair Ratio" of 32.61x for Lonza Group, which is the P/E that would typically be expected given factors such as its earnings growth profile, industry, profit margins, market cap and risks.
This Fair Ratio can be more informative than a simple peer or industry comparison because it adjusts for those company specific factors rather than assuming one size fits all. Comparing the Fair Ratio of 32.61x to the current P/E of 39.05x suggests the shares are pricing in more than this framework would imply.
Result: OVERVALUED
P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 98 top founder-led companies .
Upgrade Your Decision Making: Choose your Lonza Group Narrative
Earlier it was mentioned that there is an even better way to understand valuation. Narratives on Simply Wall St let you turn your view of Lonza Group into a clear story that connects assumptions about future revenue, earnings and margins to a financial forecast, then to a fair value you can compare with today's price to assess whether the stock appears attractive or expensive. Because Narratives sit inside the Community page and update as news or results come in, different investors can express very different views. For example, one Narrative might lean toward the higher fair value implied by a CHF 815.00 target, while another takes the more cautious stance closer to CHF 482.01. This gives you a simple, visual way to see where your own expectations sit on that spectrum.
Do you think there's more to the story for Lonza Group? Head over to our Community to see what others are saying!
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include LONN.SW .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
